LifeMine Closes Watertown's Largest Funding Round of 2026 and EyePoint's Phase 3 Miss
Plus a flurry of clinical trial updates and quarterly reports
What we're looking forward to in 2026
Neumora's positive clinical data , new tenants at the Arsenal, and more
Labshares Expanding to Watertown
Neumora's Wegovy alternative, Dyno announces manufacturing pact, and more